REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Inmunologia y Diagnostico Especializado Ide Sas (Colombia)

Main Activities: Other Ambulatory Health Care Services
Full name: Inmunologia y Diagnostico Especializado Ide Sas Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

The company Inmunologia Y Diagnostico Especializado Ltda I D E is primarily engaged in ambulatory health care services and related activities. It's been operating in the Colombian market since 1998.

Headquarters
Cr 9 # 48-40 Cs 402
Bogota D.C.; Bogota D.C; Postal Code: 0201

Contact Details: Purchase the Inmunologia y Diagnostico Especializado Ide Sas report to view the information.

Basic Information
Total Employees:
Purchase the Inmunologia y Diagnostico Especializado Ide Sas report to view the information.
Outstanding Shares:
Purchase the Inmunologia y Diagnostico Especializado Ide Sas report to view the information.
Incorporation Date:
January 23, 1998
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Inmunologia y Diagnostico Especializado Ide Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
29.1%▲
Total operating revenue
29.1%▲
Operating profit (EBIT)
194.08%▲
EBITDA
190.4%▲
Net Profit (Loss) for the Period
222.24%▲
Total assets
148.89%▲
Total equity
123.43%▲
Operating Profit Margin (ROS)
8.16%▲
Net Profit Margin
5.3%▲
Return on Equity (ROE)
23.47%▲
Quick Ratio
0.12%▲
Cash Ratio
0.01%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo